Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response

Revital Yefidoff-Freedman, Jing Fan, Lu Yan, Qingwen Zhang, Guillermo Rodrigo Reis Dos Santos, Sandeep Rana, Jacob I. Contreras, Rupam Sahoo, Debin Wan, Jun Young, Karina Luiza Dias Teixeira, Christophe Morisseau, Jose Halperin, Bruce Hammock, Amarnath Natarajan, Peimin Wang, Michael Chorev, Bertal H. Aktas

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Heme-regulated inhibitor (HRI), an eukaryotic translation initiation factor 2 alpha (eIF2α) kinase, plays critical roles in cell proliferation, differentiation, adaptation to stress, and hemoglobin disorders. HRI phosphorylates eIF2α, which couples cellular signals, including endoplasmic reticulum (ER) stress, to translation. We previously identified 1,3-diarylureas and 1-((1,4-trans)-4-aryloxycyclohexyl)-3-arylureas (cHAUs) as specific activators of HRI that trigger the eIF2α phosphorylation arm of ER stress response as molecular probes for studying HRI biology and its potential as a druggable target. To develop drug-like cHAUs needed for in vivo studies, we undertook bioassay-guided structure-activity relationship studies and tested them in the surrogate eIF2α phosphorylation and cell proliferation assays. We further evaluated some of these cHAUs in endogenous eIF2α phosphorylation and in the expression of the transcription factor C/EBP homologous protein (CHOP) and its mRNA, demonstrating significantly improved solubility and/or potencies. These cHAUs are excellent candidates for lead optimization for development of investigational new drugs that potently and specifically activate HRI.

Original languageEnglish (US)
Pages (from-to)5392-5406
Number of pages15
JournalJournal of Medicinal Chemistry
Volume60
Issue number13
DOIs
StatePublished - Jul 13 2017

Fingerprint

Eukaryotic Initiation Factor-2
Endoplasmic Reticulum Stress
Heme
Phosphorylation
Transcription Factor CHOP
Cell Proliferation
Investigational Drugs
Eukaryotic Initiation Factors
Molecular Probes
Structure-Activity Relationship
Biological Assay
Solubility
Cell Differentiation
Hemoglobins
Transcription Factors
Phosphotransferases
Messenger RNA
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response. / Yefidoff-Freedman, Revital; Fan, Jing; Yan, Lu; Zhang, Qingwen; Dos Santos, Guillermo Rodrigo Reis; Rana, Sandeep; Contreras, Jacob I.; Sahoo, Rupam; Wan, Debin; Young, Jun; Dias Teixeira, Karina Luiza; Morisseau, Christophe; Halperin, Jose; Hammock, Bruce; Natarajan, Amarnath; Wang, Peimin; Chorev, Michael; Aktas, Bertal H.

In: Journal of Medicinal Chemistry, Vol. 60, No. 13, 13.07.2017, p. 5392-5406.

Research output: Contribution to journalArticle

Yefidoff-Freedman, R, Fan, J, Yan, L, Zhang, Q, Dos Santos, GRR, Rana, S, Contreras, JI, Sahoo, R, Wan, D, Young, J, Dias Teixeira, KL, Morisseau, C, Halperin, J, Hammock, B, Natarajan, A, Wang, P, Chorev, M & Aktas, BH 2017, 'Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response', Journal of Medicinal Chemistry, vol. 60, no. 13, pp. 5392-5406. https://doi.org/10.1021/acs.jmedchem.7b00059
Yefidoff-Freedman, Revital ; Fan, Jing ; Yan, Lu ; Zhang, Qingwen ; Dos Santos, Guillermo Rodrigo Reis ; Rana, Sandeep ; Contreras, Jacob I. ; Sahoo, Rupam ; Wan, Debin ; Young, Jun ; Dias Teixeira, Karina Luiza ; Morisseau, Christophe ; Halperin, Jose ; Hammock, Bruce ; Natarajan, Amarnath ; Wang, Peimin ; Chorev, Michael ; Aktas, Bertal H. / Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response. In: Journal of Medicinal Chemistry. 2017 ; Vol. 60, No. 13. pp. 5392-5406.
@article{18c3e19c9c504e878c70d7269f53ff50,
title = "Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response",
abstract = "Heme-regulated inhibitor (HRI), an eukaryotic translation initiation factor 2 alpha (eIF2α) kinase, plays critical roles in cell proliferation, differentiation, adaptation to stress, and hemoglobin disorders. HRI phosphorylates eIF2α, which couples cellular signals, including endoplasmic reticulum (ER) stress, to translation. We previously identified 1,3-diarylureas and 1-((1,4-trans)-4-aryloxycyclohexyl)-3-arylureas (cHAUs) as specific activators of HRI that trigger the eIF2α phosphorylation arm of ER stress response as molecular probes for studying HRI biology and its potential as a druggable target. To develop drug-like cHAUs needed for in vivo studies, we undertook bioassay-guided structure-activity relationship studies and tested them in the surrogate eIF2α phosphorylation and cell proliferation assays. We further evaluated some of these cHAUs in endogenous eIF2α phosphorylation and in the expression of the transcription factor C/EBP homologous protein (CHOP) and its mRNA, demonstrating significantly improved solubility and/or potencies. These cHAUs are excellent candidates for lead optimization for development of investigational new drugs that potently and specifically activate HRI.",
author = "Revital Yefidoff-Freedman and Jing Fan and Lu Yan and Qingwen Zhang and {Dos Santos}, {Guillermo Rodrigo Reis} and Sandeep Rana and Contreras, {Jacob I.} and Rupam Sahoo and Debin Wan and Jun Young and {Dias Teixeira}, {Karina Luiza} and Christophe Morisseau and Jose Halperin and Bruce Hammock and Amarnath Natarajan and Peimin Wang and Michael Chorev and Aktas, {Bertal H.}",
year = "2017",
month = "7",
day = "13",
doi = "10.1021/acs.jmedchem.7b00059",
language = "English (US)",
volume = "60",
pages = "5392--5406",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "13",

}

TY - JOUR

T1 - Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response

AU - Yefidoff-Freedman, Revital

AU - Fan, Jing

AU - Yan, Lu

AU - Zhang, Qingwen

AU - Dos Santos, Guillermo Rodrigo Reis

AU - Rana, Sandeep

AU - Contreras, Jacob I.

AU - Sahoo, Rupam

AU - Wan, Debin

AU - Young, Jun

AU - Dias Teixeira, Karina Luiza

AU - Morisseau, Christophe

AU - Halperin, Jose

AU - Hammock, Bruce

AU - Natarajan, Amarnath

AU - Wang, Peimin

AU - Chorev, Michael

AU - Aktas, Bertal H.

PY - 2017/7/13

Y1 - 2017/7/13

N2 - Heme-regulated inhibitor (HRI), an eukaryotic translation initiation factor 2 alpha (eIF2α) kinase, plays critical roles in cell proliferation, differentiation, adaptation to stress, and hemoglobin disorders. HRI phosphorylates eIF2α, which couples cellular signals, including endoplasmic reticulum (ER) stress, to translation. We previously identified 1,3-diarylureas and 1-((1,4-trans)-4-aryloxycyclohexyl)-3-arylureas (cHAUs) as specific activators of HRI that trigger the eIF2α phosphorylation arm of ER stress response as molecular probes for studying HRI biology and its potential as a druggable target. To develop drug-like cHAUs needed for in vivo studies, we undertook bioassay-guided structure-activity relationship studies and tested them in the surrogate eIF2α phosphorylation and cell proliferation assays. We further evaluated some of these cHAUs in endogenous eIF2α phosphorylation and in the expression of the transcription factor C/EBP homologous protein (CHOP) and its mRNA, demonstrating significantly improved solubility and/or potencies. These cHAUs are excellent candidates for lead optimization for development of investigational new drugs that potently and specifically activate HRI.

AB - Heme-regulated inhibitor (HRI), an eukaryotic translation initiation factor 2 alpha (eIF2α) kinase, plays critical roles in cell proliferation, differentiation, adaptation to stress, and hemoglobin disorders. HRI phosphorylates eIF2α, which couples cellular signals, including endoplasmic reticulum (ER) stress, to translation. We previously identified 1,3-diarylureas and 1-((1,4-trans)-4-aryloxycyclohexyl)-3-arylureas (cHAUs) as specific activators of HRI that trigger the eIF2α phosphorylation arm of ER stress response as molecular probes for studying HRI biology and its potential as a druggable target. To develop drug-like cHAUs needed for in vivo studies, we undertook bioassay-guided structure-activity relationship studies and tested them in the surrogate eIF2α phosphorylation and cell proliferation assays. We further evaluated some of these cHAUs in endogenous eIF2α phosphorylation and in the expression of the transcription factor C/EBP homologous protein (CHOP) and its mRNA, demonstrating significantly improved solubility and/or potencies. These cHAUs are excellent candidates for lead optimization for development of investigational new drugs that potently and specifically activate HRI.

UR - http://www.scopus.com/inward/record.url?scp=85024397849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024397849&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.7b00059

DO - 10.1021/acs.jmedchem.7b00059

M3 - Article

C2 - 28590739

AN - SCOPUS:85024397849

VL - 60

SP - 5392

EP - 5406

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 13

ER -